Roberto Costillas Perez: Vaginal Microbiota’s Role in Assisted Reproduction Outcomes
Roberto Costillas Perez, Founder and CEO at Fertypharm, shared a post on LinkedIn:
“Vaginal Microbiota and Outcomes in Assisted Reproduction (Summary)
A Lactobacillus-dominated vaginal microbiota, especially L. crispatus, favors an acidic and protective environment, associated with better outcomes in assisted reproduction.
Vaginal dysbiosis (elevated pH, predominance of anaerobes like Gardnerella, Prevotella or Atopobium) correlates with lower implantation rates, higher miscarriage and worse overall prognosis.
Impact on Reproductive Outcomes
Lactobacillus-dominated Microbiota
- Implantation Rate: 40–60%
- Clinical Pregnancy: 45–65%
- Spontaneous Miscarriage: 10–20%
- Live Birth: 35–55% per transfer
Vaginal Dysbiosis
- Implantation: reduction of ~30–40%
- Clinical Pregnancy: 20–35%
- Miscarriage: 20–30%
- Live Birth: 15–30% per transfer
Clinical Management
1. Accessible Basic Screening
- A simple vaginal pH strip is a quick and useful method:
- pH > 4.5 → suggests dysbiosis or bacterial vaginosis.
- It allows identifying patients who could benefit from a more detailed assessment in assisted reproduction contexts.
2. When to Study Vaginal Microbiota
Indicated in:
- Repeated implantation failures
- Recurrent miscarriages
- Recurrent vaginosis or suspicion of clinically relevant dysbiosis
- Not recommended as routine screening for all patients.
3. Recommended Interventions
- Oral probiotics with lactobacilli
- They can be a good strategy to promote or restore a eubiotic environment before and during assisted reproduction cycles.
- Evidence particularly supports strains like L. rhamnosus and L. Plantarum and L. Crispatus.
- Antibiotic treatment only if documented dysbiosis exists (PCR, NGS or clinical with elevated pH and symptoms), avoiding indiscriminate empirical use.
- Re-evaluation (pH or specific tests) before embryo transfer in cases of prior dysbiosis.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 14, 2026, 17:27Giulia Zamagni: Critical Gaps in Machine Learning Models for Fetal Growth Restriction
-
Jan 14, 2026, 17:25Structured Multidisciplinary Pathways for Endometriosis – Fondation Endométriose
-
Jan 14, 2026, 17:23Daniel Roshan: Maternal Nail Polish Use and Potential Fetal Exposure
-
Jan 14, 2026, 17:21Rethinking Soy for Women With Endometriosis – Fertility Plus
-
Jan 14, 2026, 17:19Leili Mohebnasab: Understanding Placental Health Through Epigenetics
-
Jan 14, 2026, 17:17High Estradiol and Placental Pathology in Fresh IVF Pregnancies – Fertility and Sterility
-
Jan 12, 2026, 16:03New Insights Into Estrogen Receptor Alpha Regulation in the Endometrium – Fertility and Sterility
-
Jan 12, 2026, 15:37From Innovation to Practice: Standards for Embryo Diagnostic Trials – Fertility and Sterility
-
Jan 12, 2026, 14:47HFEA Updates Choose a Fertility Clinic Tool to Improve Success Reporting
